Intuitive Surgical shares dipped recently after the company issued a cautious forecast, but patient investors may find this a compelling entry point.
Investors React to Slowing Growth at Robotic Surgery Leader
Despite strong recent performance, a tempered outlook has investors reassessing Intuitive Surgical’s stock.
- Intuitive Surgical’s revenue grew 19% in the fourth quarter of 2025,but its 2026 guidance suggests a slowdown.
- The company anticipates procedure volume growth of 13% to 15% this year, compared to 18% in 2025.
- Despite near-term volatility, Intuitive Surgical’s long-term prospects remain attractive due to its market leadership and competitive advantages.
Intuitive Surgical (ISRG, a leading medical device specialist, faced headwinds last year, including challenges stemming from trade policies. Now, the healthcare giant is navigating another period of scrutiny as investors digest its latest financial update. While the company’s fourth-quarter results were solid, its guidance for the year ahead has sparked concern.
what’s driving the market’s reaction? Intuitive Surgical’s revenue increased 19% year-over-year to $2.87 billion in the fourth quarter of 2025.The number of procedures performed using its da Vinci surgical system rose 17% during the same period. Earnings per share also saw a healthy increase, climbing 17.6% year-over-year to $2.21.
however,the company’s forecast for fiscal 2026-projecting procedure volume growth of 13% to 15%,down from 18% in 2025-appears to be the primary source of investor unease. This metric is crucial, as increased procedure volume directly translates to higher sales of instruments and accessories, the core of Intuitive Surgical’s recurring revenue stream.
avg Vol
1.8M
Gross Margin
70.56%
Why Intuitive Surgical Remains a Long-Term Buy
Despite the anticipated slowdown, Intuitive Surgical possesses important long-term potential. The robotic-assisted surgery market, which it dominates, remains largely untapped. This is further bolstered by demographic trends, such as the world’s aging population, which will drive demand for a wider range of surgical procedures.
Intuitive Surgical benefits from a strong competitive position, characterized by high switching costs and substantial barriers to entry. Moreover, the extensive real-world data accumulated on its devices demonstrates improved patient outcomes.
Looking at valuation, Intuitive Surgical appears less expensive when considering its expected growth. the company’s price-to-earnings-to-growth (PEG) ratio is 3.2. While above the typically valued range (below 2), this valuation seems reasonable given Intuitive Surgical’s prospects and competitive advantages.
Short-term volatility is absolutely possible, but over the long run, Intuitive Surgical appears to be an attractive stock for buy-and-hold investors.
Worth a look
